Wenzhou Medical University; Chinese: 温州医科大学; pinyin: Wēnzhōu Yīkē Dàxué, designated as a key university in Wenzhou, Zhejiang, is an institution of higher learning under the leadership of Zhejiang Provincial Government.

During the past decade, The Second Affiliated Hospital of Wenzhou Medical University conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Wenzhou Medical University" #1 sponsor was "Wenzhou Medical University" with 16 trials, followed by "Second Affiliated Hospital of Wenzhou Medical University" with 8 trials sponsored, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 5 trials sponsored, "Yifan Feng" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Wenzhou Medical University" #1 collaborator was "Wenzhou Medical University" with 5 trials as a collaborator, "First Affiliated Hospital of Wenzhou Medical University" with 3 trials as a collaborator, "Second Affiliated Hospital of Wenzhou Medical University" with 3 trials as a collaborator, "Central South University" with 2 trials as a collaborator and "Wuhan University" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Wenzhou Medical University" are "Dry Eye" (3 trials), "Quality of Life" (3 trials), "Airway Responsiveness" (2 trials), "Asthma" (2 trials) and "Cataract" (2 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Wenzhou Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Wenzhou Medical University" are "Drug" (15 trials), "Device" (10 trials), "Other" (8 trials), "Procedure" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "2ml peripheral venous blood was collected to detect genetic genes" (1 trials), "Acetyllevocarnitine Hydrochloride Tablets" (1 trials) and "Angiography-derived FFR" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Wenzhou Medical University" are 47 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital of Wenzhou Medical University". undefined are not yet recruiting, 13 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in The Second Affiliated Hospital of Wenzhou Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Wenzhou Medical University, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".